RxDoctor Payments Data
★ My doctorsLook up a doctor →

Andrew Martorella

Endocrinology, Diabetes & Metabolism · New York, NYNPI 1639140437

Payments from drug & device makers

$37,060in general payments, 2019–2025

Across 1,171 payments — averaging $31.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Corcept Therapeutics$4K
  • Aytu Biopharma, Inc.$3K
  • Sanofi-aventis U.S. LLC$3K
  • Novo Nordisk$3K
  • Amgen$3K
  • plus $17K from 54 others

What the payments were for

  • Consulting fees$5,25014%
  • Speaking & faculty fees$3,0008%
  • Travel & lodging$2901%
  • Food & beverage$28,44177%
  • Education$780%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie108$4,710
Corcept Therapeutics29$3,926
Aytu Biopharma, Inc.12$3,359
Sanofi-aventis U.S. LLC94$2,922
Novo Nordisk150$2,550
Amgen(2 entities)86$2,547
Lilly USA, LLC114$2,052
Mannkind Corporation49$1,801
Boehringer Ingelheim59$1,694
AstraZeneca(2 entities)68$1,347
Xeris Pharmaceuticals, Inc.22$774
Antares Pharma, Inc.33$756
Pfizer31$657
Cequr Corporation2$545
Bayer25$475
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$445
Amryt Pharma Holdings Ltd6$438
Intuity Medical Inc3$371
IBSA Pharma Inc.19$357
Johnson & Johnson(2 entities)13$356
Currax Pharmaceuticals LLC20$319
Insulet Corporation15$316
Amneal Pharmaceuticals LLC18$306
Merck23$291
Esperion Therapeutics, Inc.3$275
Medtronic(2 entities)10$240
Astellas Pharma US Inc9$223
Abbott11$223
BETA Bionics, Inc.5$211
EUSA Pharma (US) LLC2$202
Ascendis Pharma Endocrinology Inc4$189
Intra-sana Laboratories7$167
Acella Pharmaceuticals, LLC8$136
Ipsen Biopharmaceuticals, Inc6$128
Idorsia Pharmaceuticals US Inc6$128
Tolmar, Inc.8$127
GRT US Holding, Inc.5$105
Vivus LLC4$73
Acerus Pharmaceuticals Corporation4$73
Madrigal Pharmaceuticals4$73
Chiesi USA, Inc.4$72
Avion Pharmaceuticals5$68
Radius Health, Inc.3$62
Lifescan, Inc.3$61
Ascend Therapeutics US, LLC3$59
UCB, Inc.3$58
Tandem Diabetes Care, Inc.3$54
Verity Pharmaceuticals Inc.3$50
BD3$48
Vistapharm, Inc.3$48
Nevro Corp.2$48
Regeneron Healthcare Solutions, Inc.2$45
Halozyme Inc2$43
Dexcom, Inc.2$39
Azurity Pharmaceuticals, Inc.2$38
Biohaven Pharmaceutical Holding Company Ltd.2$38
Eisai Inc.2$37
Novartis2$36
Recordati_rare_diseases_inc.2$31
Kyowa Kirin, Inc.1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,060 in reported general payments places this provider in the 85th percentile of 804 endocrinology, diabetes & metabolism providers in New York.

See all endocrinology, diabetes & metabolism providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide486$538,750
OzempicSemaglutide442$453,567
ProliaDenosumab67$116,633
JardianceEmpagliflozin93$93,661
TrulicityDulaglutide79$81,590
Teriparatide14$45,701
JanuviaSitagliptin Phosphate28$40,079
SynthroidLevothyroxine Sodium339$35,571
Janumet XrSitagliptin Phos/Metformin Hcl62$34,890
JanumetSitagliptin Phos/Metformin Hcl32$31,806
XyostedTestosterone Enanthate46$28,608
Tresiba Flextouch U-200Insulin Degludec37$26,096
Synjardy XrEmpagliflozin/Metformin Hcl29$23,697
Jentadueto XrLinagliptin/Metformin Hcl16$21,549
AfrezzaInsulin Regular, Human11$18,864

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$2,052$624,507585 claims
Novo NordiskOzempic$2,550$453,567442 claims
Boehringer IngelheimJardiance, Synjardy Xr, Jentadueto Xr$1,694$138,907138 claims
AmgenProlia$2,547$116,63367 claims
MerckJanuvia, Janumet Xr, Janumet$291$106,774122 claims
AbbVieSynthroid, Armour Thyroid$4,710$38,767359 claims
Antares Pharma, Inc.Xyosted$756$28,60846 claims
Mannkind CorporationAfrezza$1,801$18,86411 claims
AstraZenecaFarxiga$1,347$18,75616 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$2,922$14,23425 claims
PfizerEliquis$657$7,07612 claims
IBSA Pharma Inc.Tirosint$357$4,14819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 804 endocrinology, diabetes & metabolism providers in New York.

Other endocrinology, diabetes & metabolism in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →